Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Lymphotoxin β receptor signalling executes Helicobacter pylori -driven gastric inflammation in a T4SS-dependent manner

View through CrossRef
Objective Lymphotoxin β receptor (LTβR) signalling has been implicated in inflammation-associated tumour development in different tissues. We have analysed the role of LTβR and alternative NF-κB signalling in Helicobacter pylori- mediated gastric inflammation and pathology. Design We analysed several ligands and receptors of the alternative NF-κB pathway, RelB, p52 nuclear translocation and target genes in tissue samples of H. pylori -infected patients with different degrees of gastritis or early gastric tumours by in situ hybridisation, immunohistochemistry, Western blot and real-time PCR analyses. Molecular mechanisms involved in LTβR activation by H. pylori were assessed in vitro using human gastric cancer cell lines and distinct H. pylori isolates. The effects of blocking or agonistically activating LTβR on gastric pathology during challenge with a human pathogenic H. pylori strain were studied in a mouse model. Results Among the tested candidates, LT was significantly increased and activated alternative NF-κB signalling was observed in the gastric mucosa of H. pylori -infected patients. H. pylori induced LTβR–ligand expression in a type IV secretion system-dependent but CagA-independent manner, resulting in activation of the alternative NF-κB pathway, which was further enhanced by blocking canonical NF-κB during infection. Blocking LTβR signalling in vivo suppressed H. pylori- driven gastritis, whereas LTβR activation in gastric epithelial cells of infected mice induced a broadened pro-inflammatory chemokine milieu, resulting in exacerbated pathology. Conclusions LTβR-triggered activation of alternative NF-κB signalling in gastric epithelial cells executes H. pylori -induced chronic gastritis, representing a novel target to restrict gastric inflammation and pathology elicited by H. pylori , while exclusively targeting canonical NF-κB may aggravate pathology by enhancing the alternative pathway.
Title: Lymphotoxin β receptor signalling executes Helicobacter pylori -driven gastric inflammation in a T4SS-dependent manner
Description:
Objective Lymphotoxin β receptor (LTβR) signalling has been implicated in inflammation-associated tumour development in different tissues.
We have analysed the role of LTβR and alternative NF-κB signalling in Helicobacter pylori- mediated gastric inflammation and pathology.
Design We analysed several ligands and receptors of the alternative NF-κB pathway, RelB, p52 nuclear translocation and target genes in tissue samples of H.
pylori -infected patients with different degrees of gastritis or early gastric tumours by in situ hybridisation, immunohistochemistry, Western blot and real-time PCR analyses.
Molecular mechanisms involved in LTβR activation by H.
pylori were assessed in vitro using human gastric cancer cell lines and distinct H.
pylori isolates.
The effects of blocking or agonistically activating LTβR on gastric pathology during challenge with a human pathogenic H.
pylori strain were studied in a mouse model.
Results Among the tested candidates, LT was significantly increased and activated alternative NF-κB signalling was observed in the gastric mucosa of H.
pylori -infected patients.
H.
pylori induced LTβR–ligand expression in a type IV secretion system-dependent but CagA-independent manner, resulting in activation of the alternative NF-κB pathway, which was further enhanced by blocking canonical NF-κB during infection.
Blocking LTβR signalling in vivo suppressed H.
pylori- driven gastritis, whereas LTβR activation in gastric epithelial cells of infected mice induced a broadened pro-inflammatory chemokine milieu, resulting in exacerbated pathology.
Conclusions LTβR-triggered activation of alternative NF-κB signalling in gastric epithelial cells executes H.
pylori -induced chronic gastritis, representing a novel target to restrict gastric inflammation and pathology elicited by H.
pylori , while exclusively targeting canonical NF-κB may aggravate pathology by enhancing the alternative pathway.

Related Results

The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
<p dir="ltr"><b>Background</b></p><p dir="ltr">Helicobacter pylori (H. pylori) infects nearly half of the world's population and causes gastritis, pep...
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
<p dir="ltr"><b>Background</b></p><p dir="ltr">Helicobacter pylori (H. pylori) infects nearly half of the world's population and causes gastritis, pep...
Helicobacter pylori and gastric cancer
Helicobacter pylori and gastric cancer
Introduction: According to GLOBOCAN estimates for 2018, gastric cancer was the fifth most common cancer and the third most common cause of death from malignant diseases in the worl...
Helicobacter pylori-Positive Gastric Biopsies—Association with Clinical Predictors
Helicobacter pylori-Positive Gastric Biopsies—Association with Clinical Predictors
Introduction: Although Helicobacter pylori’s role in gastric oncogenesis is well-known, only a fraction of infected patients develop cancer. Hence, more factors are supposed to be ...
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Abstract Introduction: Infection with Helicobacter pylori is one of the most frequent chronic bacterial illnesses in humans, infecting more than half of the world's populat...

Back to Top